Rocket Lab (RKLB) Stock; Steady Despite $293 Price Target as Neutron Risks Remain

TLDRs;

• Morgan Stanley sees major long-term upside for Rocket Lab, but investors remain cautious about execution and valuation.
• Analysts believe Rocket Lab is evolving beyond launches into a diversified space infrastructure company with recurring revenue potential.
• Revenue growth, defense contracts, and the Iridium acquisition strengthen Rocket Lab’s long-term commercial positioning.
• Investors continue watching Neutron development because delays could significantly impact Rocket Lab’s future growth strategy.

Rocket Lab (NASDAQ: RKLB) stock traded little changed on Wednesday despite receiving a major vote of confidence from Morgan Stanley, which raised its bull-case price target to $293 from $185. The higher target underscores growing optimism about the company’s long-term prospects, but investors remain cautious as Rocket Lab prepares for its next stage of growth, led by the development of its Neutron rocket.

The stock steadied after suffering a sharp decline earlier in the week during a broader selloff across space-related companies. While analysts continue to highlight Rocket Lab’s expanding opportunities in satellite infrastructure and defense, many investors are balancing those prospects against execution risks tied to its ambitious expansion plans.

Morgan Stanley Sees Bigger Opportunity

Morgan Stanley believes Rocket Lab is evolving into much more than a launch provider. Analysts argue that the future of the commercial space industry will be driven by recurring satellite services, communications networks, and integrated space infrastructure rather than launch operations alone.

Rocket Lab USA, Inc., RKLB

That outlook prompted the investment bank to significantly increase its optimistic valuation scenario. The firm sees Rocket Lab building an ecosystem that combines launch services, spacecraft manufacturing, satellite operations, and communications capabilities under one company, creating multiple long-term revenue streams.

This strategy has drawn comparisons with SpaceX, whose launch business complements its Starlink satellite internet network. Although Rocket Lab remains much smaller, analysts believe its long-term vision follows a similar path toward becoming a diversified space infrastructure company.

Despite the bullish outlook, Rocket Lab shares remained near $83, suggesting investors are waiting for additional operational milestones before assigning higher valuations.

Growth Strategy Gains Momentum

Rocket Lab continues to report strong financial and operational progress. During its latest reported quarter, revenue reached $200.3 million, marking a 63.5% increase from the previous year. The company also reported a backlog of approximately $2.2 billion, reflecting strong customer demand and a healthy pipeline of contracted business.

Morgan Stanley reiterated Rocket Lab at Overweight with a $105 price target and raised its bull case to $293 from $185, citing the Iridium acquisition, launch and connectivity upside, and $RKLB’s move toward a more vertically integrated space platform. pic.twitter.com/iaQT6f0wAG

— Wall St Engine (@wallstengine) July 8, 2026

Beyond commercial activity, Rocket Lab continues strengthening its position in the defense sector. The company recently completed its role in the U.S. Space Force’s VICTUS HAZE mission, successfully delivering launch services and spacecraft operations within mission deadlines.

Another major growth catalyst is Rocket Lab’s planned $8 billion acquisition of Iridium. The deal would provide access to a global low-Earth-orbit satellite network, valuable communications spectrum, and more than 2.5 million subscribers. Management believes the acquisition will strengthen recurring revenue while expanding the company’s presence across the broader space economy.

Neutron Remains Key Risk

Despite the company’s growing business, investors continue to focus on the successful development of the Neutron rocket. The next-generation vehicle is expected to carry larger payloads and enable Rocket Lab to compete for bigger commercial and government launch contracts.

However, rocket development carries significant technical and financial risks. Delays in testing, certification, or production could postpone future revenue opportunities and increase development costs. Investors are also watching whether the Iridium acquisition and Neutron program together could place additional pressure on Rocket Lab’s finances.

For now, Rocket Lab offers investors a compelling long-term growth story supported by expanding revenue, government contracts, and strategic acquisitions. Still, Wall Street appears determined to see successful execution of the Neutron program before fully embracing the company’s ambitious valuation outlook.